Second, NEMO is required for the constitutive and chronic activation of canonical NF-κB signaling that occurs in a variety of cancers, and is required for the ability of these cancer cells to proliferate or survive (i.e., avoid apoptosis) [10, 13, 14]. Here, NFKB1 is linked to cancer.